Veru VERU
NASDAQ VERU
$2.56 +0.03 (+1.39%)
At close: Sep 29, 2026 · 4:00 PM EDT

Veru (VERU) Total Current Liabilities (2010 - 2026)

Updated

Veru (VERU) posted Total Current Liabilities of $6.16 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 7.9% from $6.68 million a year earlier but up 14.2% from the prior quarter.

Analysis

Veru (VERU) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Veru's Total Current Liabilities came in at $7.79 million, down 34.4% from FY2024.

  • Annual Total Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
  • In prior fiscal years, Veru's Total Current Liabilities was $11.87 million in FY2024 (-33.4%), $17.81 million in FY2023 (-54.0%), $38.71 million in FY2022 (+145.5%) and $15.77 million in FY2021 (+7.1%).
  • Quarterly Total Current Liabilities has run from a low of $5.39 million in fiscal Q2 2026 to a high of $38.71 million in fiscal Q4 2022 over five years.
  • On a year-over-year basis, Total Current Liabilities increased in 1 of the last eight quarters, with an average decline of 26.0%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q1 2023, with growth of 168.9%; the weakest was fiscal Q2 2024, with a decline of 72.1%.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $5.39 million (Q2 2026), $7.13 million (Q1 2026) and $7.79 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Veru 58.32 Mn -51.96 Mn - 6.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.16 Mn
Mar 31, 2026 5.39 Mn
Dec 31, 2025 7.13 Mn
Sep 30, 2025 7.79 Mn
Jun 30, 2025 6.68 Mn
Mar 31, 2025 5.62 Mn
Dec 31, 2024 6.35 Mn
Sep 30, 2024 11.87 Mn
Jun 30, 2024 10.62 Mn
Mar 31, 2024 9.57 Mn
Dec 31, 2023 16.62 Mn
Sep 30, 2023 17.81 Mn
Jun 30, 2023 26.44 Mn
Mar 31, 2023 34.25 Mn
Dec 31, 2022 37.48 Mn
Sep 30, 2022 38.71 Mn
Jun 30, 2022 27.81 Mn
Mar 31, 2022 21.18 Mn
Dec 31, 2021 13.94 Mn
Sep 30, 2021 15.77 Mn
API Access

Veru Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VERU&period=max&api_key=YOUR_API_KEY